These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 8834020

  • 21. Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patients.
    Tabone M, Secreto P, Marini C, Bonardi R, Boero M, Taraglio S, Ercole E, Sallio Bruno F, Pera A.
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):287-91. PubMed ID: 9096432
    [Abstract] [Full Text] [Related]

  • 22. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
    Ciccorossi P, Filipponi F, Oliveri F, Campani D, Colombatto P, Bonino F, Campa M, Maltinti G, Mosca F, Brunetto MR.
    J Viral Hepat; 2003 May; 10(3):168-73. PubMed ID: 12753334
    [Abstract] [Full Text] [Related]

  • 23. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection.
    Hellström UB, Sylvan SP, Decker RH, Sönnerborg A.
    J Med Virol; 1993 Apr; 39(4):325-32. PubMed ID: 8388029
    [Abstract] [Full Text] [Related]

  • 24. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A, Yang G, Dreyfus G, Rouquié P, Durant J, Rampal A, Rampal P, Benzaken S.
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [Abstract] [Full Text] [Related]

  • 25. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
    el-Gohary A, Hosny AM, Fawaz N, Heiba A, Abdalla E, Kawano F, Kiyokawa T.
    Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
    [Abstract] [Full Text] [Related]

  • 26. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreño V.
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome.
    Lopes EP, Granato CH, Lanzoni V, Granero L, Paranhos-Baccala G, Tomiyama H, Silva AE, Ferraz ML.
    Mem Inst Oswaldo Cruz; 2000 Sep; 95(5):717-20. PubMed ID: 10998223
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of hepatitis C virus serotypes and IgM anti-HCV antibodies in two groups of anti-HCV positive subjects in south-east Italy.
    Volpe A, Pellegrino A, Ranieri C, Picciarelli C, Buongiorno R, Dentico P.
    New Microbiol; 2002 Apr; 25(2):111-6. PubMed ID: 12019715
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state.
    Morisco F, Del Vecchio Blanco G, Tuccillo C, Galli C, Cirino S, Caporaso N.
    Res Virol; 1998 Apr; 149(5):277-82. PubMed ID: 9879605
    [Abstract] [Full Text] [Related]

  • 31. Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units.
    Oliva JA, Ercilla G, Mallafre JM, Bruguera M, Carrió J, Pereira BJ.
    Int J Artif Organs; 1995 Feb; 18(2):73-7. PubMed ID: 7558399
    [Abstract] [Full Text] [Related]

  • 32. IgM antibody response to hepatitis C virus in end-stage renal disease.
    Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Erba G, Pagano A, Locatelli F.
    Nephrol Dial Transplant; 1996 Feb; 11(2):314-8. PubMed ID: 8671785
    [Abstract] [Full Text] [Related]

  • 33. Recent approach for diagnosis of early HCV infection.
    el-Sayed Zaki M, el-Adrosy H.
    Egypt J Immunol; 2004 Feb; 11(1):123-9. PubMed ID: 15724394
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis C virus RNA and hepatitis C virus antibody in the serum of patients with abnormal liver function.
    Ichimura H, Tamura I, Yamada O, Takezaki E, Koda T, Kurimura O, Kurimura T.
    J Infect; 1992 Jul; 25(1):47-53. PubMed ID: 1381735
    [Abstract] [Full Text] [Related]

  • 35. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF, Elste C, Dienes HP, Michel G, Braun HB, Meyer zum Büschenfelde KH, Gerken G.
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [Abstract] [Full Text] [Related]

  • 36. Virus-specific antibody titres in different phases of hepatitis C virus infection.
    Nikolaeva LI, Blokhina NP, Tsurikova NN, Voronkova NV, Miminoshvili MI, Braginsky DM, Yastrebova ON, Booynitskaya OB, Isaeva OV, Michailov MI, Archakov AI.
    J Viral Hepat; 2002 Nov; 9(6):429-37. PubMed ID: 12431205
    [Abstract] [Full Text] [Related]

  • 37. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM, Byun BH, Choi JY, Bae SH, Kim BS, So HS, Ryu WS.
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 39. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers.
    Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T.
    J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692
    [Abstract] [Full Text] [Related]

  • 40. Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection.
    Negro F, Troonen H, Michel G, Giostra E, Albrecht M, Perrin L, Hadengue A.
    J Virol Methods; 1996 Jul; 60(2):179-82. PubMed ID: 8844624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.